April 20, 2021

Chinese COVID-19 vaccine producers such as Sinovac and CanSinoBIO are mulling technology transfers to other countries to help address the global vaccine inequity issue, company executives said at the 2021 Boao Forum for Asia (BFA) on Tuesday. 

"China plans to produce over 3 billion COVID-19 vaccines this year. The capacity can reach around 5 billion doses this year," Zheng Zhongwei, director of the Development Center for Medical Science and Technology of the National Health Commission (NHC), said at a session on COVID-19 on Tuesday during the BFA in South China's Hainan Province, noting that China has taken into consideration both domestic and global demand from the beginning of the vaccine development process. 

After production is properly established in the second half of this year, China will provide doses to more people in need through multilateral and bilateral measures, Zhong said. 

Read more:

https://www.globaltimes.cn/page/202104/1221614.shtml